Cargando…

Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer

Serous epithelial ovarian cancer (SEOC) is the most lethal gynecological cancer in the United States with disease recurrence being the major cause of morbidity and mortality. Despite recent advances in our understanding of the molecular mechanisms responsible for the development of SEOC, the surviva...

Descripción completa

Detalles Bibliográficos
Autores principales:	House, Carrie Danielle, Hernandez, Lidia, Annunziata, Christina Messineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923136/ https://www.ncbi.nlm.nih.gov/pubmed/24592355 http://dx.doi.org/10.3389/fonc.2014.00026

Ejemplares similares

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
por: House, Carrie D., et al.
Publicado: (2015)

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
por: Kim, Marianne K., et al.
Publicado: (2016)

Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models
por: Zhuang, Xiaomei, et al.
Publicado: (2023)

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
por: Zeligs, Kristen P., et al.
Publicado: (2020)

Development of a Mouse Model of Menopausal Ovarian Cancer
por: Smith, Elizabeth R., et al.
Publicado: (2014)

Driving Immune Responses in the Ovarian Tumor Microenvironment
por: Ning, Franklin, et al.
Publicado: (2021)

Advances in Tumor Screening, Imaging, and Avatar Technologies for High-Grade Serous Ovarian Cancer
por: Ohman, Anders W., et al.
Publicado: (2014)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells
por: Caminear, Michael W., et al.
Publicado: (2022)

MicroRNAs and Recent Insights into Pediatric Ovarian Cancers
por: Francis, Jessica C., et al.
Publicado: (2013)

Overcoming the challenges of drug development in platinum-resistant ovarian cancer
por: Eskander, Ramez N., et al.
Publicado: (2023)

Recent Advances in the Treatment of Breast Cancer
por: Tong, Christy W. S., et al.
Publicado: (2018)

Recent Advances on the Role of ATGL in Cancer
por: Zhang, Renshuai, et al.
Publicado: (2022)

Recent advances in vascularized tumor-on-a-chip
por: Huang, Christina Bao Xian, et al.
Publicado: (2023)

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
por: Fan, Yali, et al.
Publicado: (2022)

Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study
por: Shin, Seokyung, et al.
Publicado: (2021)

Recent Advances in Medical Therapy for Urological Cancers
por: Yuasa, Takeshi, et al.
Publicado: (2022)

Editorial: Recent advances in cervical cancer radiotherapy
por: Varlotto, John Michael, et al.
Publicado: (2023)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

The recent advances of cancer associated fibroblasts in cancer progression and therapy
por: Wu, Chenxi, et al.
Publicado: (2022)

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
por: Harrington, Brittney S., et al.
Publicado: (2020)

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
por: Filin, Ivan Y., et al.
Publicado: (2021)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

Recent advances in understanding DNA methylation of prostate cancer
por: Shin, Hyun Jin, et al.
Publicado: (2023)

Recent advances of pathomics in colorectal cancer diagnosis and prognosis
por: Wu, Yihan, et al.
Publicado: (2023)

Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism
por: Hernandez, Lidia F., et al.
Publicado: (2021)

Predicting incomplete cytoreduction in patients with advanced ovarian cancer
por: Egger, Eva K., et al.
Publicado: (2022)

Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
por: Lakshminarayanan, Harini, et al.
Publicado: (2020)

Insulin-like growth factor binding protein 5: Diverse roles in cancer
por: Waters, Jennifer A., et al.
Publicado: (2022)

Recent Advances in Meningioma Immunogenetics
por: Al-Rashed, May, et al.
Publicado: (2020)

Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
por: Chen, Run-Ze, et al.
Publicado: (2021)

Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives
por: Chen, Huan-Huan, et al.
Publicado: (2021)

Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities
por: Xue, Qin, et al.
Publicado: (2022)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
por: Akter, Salima, et al.
Publicado: (2022)

Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
por: Liu, Sha, et al.
Publicado: (2022)

Recent advances in the progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer: A review
por: Shen, Jingjing, et al.
Publicado: (2022)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma
por: Wu, Kunzhe, et al.
Publicado: (2022)

Management of infantile hemangiomas: Recent advances
por: Xu, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vuptdhc38qvh1n4aq47s8o2nmt